🇺🇸 MRK — Merck & Co., Inc.

Healthcare Compra
← Volver

Precio actual

150,33 USD

Máx. histórico

156,92

10 días

Caída desde máximo

-4,20%

Rango 52 semanas

77,58 – 156,92

Variación hoy

-1,32%

Cierre anterior

152,34

Rango de hoy

150,09 – 152,22

Volumen hoy

4.298.143

Información
Nombre completo
Merck & Co., Inc.
Divisa
USD
Mercado
NYSE
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
73.000
PER ⓘ
122,22 (puede no estar actualizado)
Dividend yield
2,23% (puede no estar actualizado)
Precio objetivo analistas
148,73 USD (puede no estar actualizado)
Primera cotización
02/01/1962
Precio actualizado
hace 2 días
Sobre la empresa

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

Dividendos repartidos Total últimos 12 meses: 3,3600 USD · Yield: 2,24%
Fecha de pago Importe por participación
03/12/2003 0,3531 USD
03/09/2003 0,3531 USD
20/08/2003 2,7443 USD
04/06/2003 0,3435 USD
05/03/2003 0,3435 USD
04/12/2002 0,3435 USD
04/09/2002 0,3435 USD
05/06/2002 0,3340 USD
06/03/2002 0,3340 USD
05/12/2001 0,3340 USD
30/08/2001 0,3340 USD
31/05/2001 0,3244 USD
07/03/2001 0,3244 USD
06/12/2000 0,3244 USD
30/08/2000 0,3244 USD
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
15/01/2019 69,75 71,46 69,75 71,09 +1,54% 2,45% 13.102.096
14/01/2019 70,89 71,03 69,75 70,01 -2,04% 1,80% 15.669.486
11/01/2019 71,28 71,51 70,75 71,47 +0,56% 1,06% 9.878.029
10/01/2019 72,21 72,21 70,11 71,07 -1,23% 2,92% 19.134.070
09/01/2019 72,41 72,81 71,87 71,96 -0,76% 1,30% 11.916.284
08/01/2019 72,40 72,72 71,84 72,51 +0,74% 1,21% 11.896.686
07/01/2019 72,66 72,97 71,96 71,98 -1,10% 1,39% 15.795.142
04/01/2019 71,32 73,00 71,22 72,78 +3,01% 2,49% 14.753.115
03/01/2019 72,10 72,49 70,47 70,65 -2,05% 2,81% 13.910.628
02/01/2019 71,84 72,51 71,18 72,13 -1,07% 1,85% 15.120.125
31/12/2018 72,35 73,19 72,19 72,91 +1,38% 1,37% 9.687.502
28/12/2018 72,40 73,07 71,40 71,92 -0,01% 2,31% 13.180.696
27/12/2018 69,92 71,93 69,43 71,93 +1,86% 3,58% 13.577.154
26/12/2018 67,72 70,64 67,72 70,61 +4,01% 4,31% 14.074.011
24/12/2018 69,21 69,56 67,64 67,89 -2,40% 2,77% 11.565.833
21/12/2018 69,61 71,04 68,91 69,56 -0,80% 3,06% 37.919.994
20/12/2018 70,09 70,73 69,31 70,12 -0,38% 2,03% 20.321.454
19/12/2018 71,26 71,80 69,72 70,39 -0,75% 2,92% 19.765.594
18/12/2018 72,14 72,31 70,19 70,93 -1,20% 2,94% 16.163.828
17/12/2018 72,49 73,37 71,43 71,78 -1,63% 2,67% 15.831.822
14/12/2018 74,27 74,46 72,74 72,98 -3,20% 2,31% 13.896.375
13/12/2018 74,67 75,46 74,43 75,39 +1,28% 1,38% 11.272.498
12/12/2018 74,21 75,15 74,16 74,44 +1,17% 1,34% 11.219.678
11/12/2018 74,35 74,72 73,03 73,58 -0,40% 2,27% 13.867.660
10/12/2018 73,90 74,22 72,39 73,87 +0,91% 2,48% 16.163.618
07/12/2018 74,64 74,71 72,61 73,21 -2,11% 2,81% 13.228.799
06/12/2018 73,44 74,78 72,35 74,78 +0,20% 3,31% 17.329.518
04/12/2018 75,67 76,52 74,52 74,63 -1,27% 2,64% 15.482.942
03/12/2018 75,88 75,94 74,69 75,59 -0,15% 1,63% 13.183.106
30/11/2018 74,27 75,85 74,16 75,71 +1,84% 2,27% 22.380.669